目的: 建立预测儿童肺炎支原体肺炎(MPP)行支气管肺泡灌洗术(BAL)次数的Nomogram模型,并分析模型的临床价值。方法: 对2023年1月至2024年1月就诊于我院的240例行BAL治疗的MPP患儿的临床资料进行回顾性收集。根据随机数字表法,将所有患儿分为训练集和验证集(比例7:3)。根据患儿行BAL治疗的次数将训练集患儿分为单次组和多次组,基于单因素分析和多因素Logistic回归分析筛选出独立危险因素,以此为基础构建Nomogram模型。模型的准确度采用校准曲线和受试者工作特征(ROC)曲线评价,临床适用范围和安全性采用临床决策曲线分析评估。结果: 单因素分析显示,单次组和多次组的BAL前热程、合并胸腔积液、肺外并发症、乳酸脱氢酶(LDH)及C反应蛋白(CRP)相比较,差异有统计学意义(P<0.05)。多因素分析显示,BAL前热程≥10 d、合并胸腔积液、有肺外并发症、LDH≥462 U·L-1及CRP≥31.4 mg·L-1是MPP患儿行多次BAL的独立危险因素(P<0.05)。基于上述危险因素构建的Nomogram模型的ROC曲线分析显示,训练集和验证集的曲线下面积(AUC)分别为0.820、0.843(P<0.05)。校正曲线分析显示,模型在训练集和验证集中拟合度较高,一致性较好。临床决策曲线分析显示,该模型在预测MPP患儿行BAL次数的方面,具有广泛的临床使用范围和较高的安全性。结论: MPP患儿多次行BAL治疗与BAL前热程、合并胸腔积液、肺外并发症及LDH、CRP水平有关。基于上述因素构建的Nomogram预测模型准确度高且临床适用范围广,为临床医生提前识别出MPP患儿多次行BAL的风险提供理论支持。 |
[1] WANG Y,YU X,LIU F,et al.Respiratory microbiota imbalance in children with Mycoplasma pneumoniae pneumonia[J].Emerg Microbes Infect,2023,12(1):2202272.
[2] TSAI T A,TSAI C K,KUO K C,et al.Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children[J].J Microbiol Immunol Infect,2021,54(4):557-565.
[3] HOGEA S P,TUDORACHE E,PESCARU C,et al.Bronchoalveolar lavage:role in the evaluation of pulmonary interstitial disease[J].Expert Rev Respir Med,2020,14(11):1117-1130.
[4] 朱艳,陈众众,刘家昌.宏基因二代测序技术在肺部阴影发热病例诊断中的应用价值[J].临床肺科杂志,2023,28(9):1368-1373.
[5] TONG C,MIAO Q,ZHENG J,et al.A novel nomogram for predicting the decision to delayed extubation after thoracoscopic lung cancer surgery[J].Ann Med,2023,55(1):800-807.
[6] 秦士想,叶永青.慢性阻塞性肺疾病合并肺癌的临床特点分析及列线图预测模型的建立[J].临床肺科杂志,2023,28(11):1682-1686.
[7] 中华医学会儿科学分会呼吸学组,《中华实用儿科临床杂志》编辑委员会.儿童肺炎支原体肺炎诊治专家共识(2015年版)[J].中华实用儿科临床杂志,2015,30(17):1304-1308.
[8] 周蒙,孟令建,刘琳,等.支原体肺炎行多次支气管镜下灌洗的影响因素分析及预测模型构建[J].徐州医科大学学报,2021,41(8):611-615.
[9] BADA-BOSCH I,PÉREZ-EGIDO L,GARCÍA-CASILLAS M A,et al.Bronchoalveolar lavage usefulness in the pediatric population[J].Cir Pediatr,2020,33(4):160-165.
[10] PATEL J M.Multisystem Inflammatory Syndrome in Children(MIS-C)[J].Curr Allergy Asthma Rep,2022,22(5):53-60.
[11] BI Y,ZHU Y,MA X,et al.Development of a scale for early prediction of refractory Mycoplasma pneumoniae pneumonia in hospitalized children[J].Sci Rep,2021,11(1):6595.
[12] CHEN Y C,HSU W Y,CHANG T H.Macrolide-resistant Mycoplasma pneumoniae infections in pediatric community-acquired pneumonia[J].Emerg Infect Dis,2020,26(7):1382-1391.
[13] GONG H,SUN B,CHEN Y,et al.The risk factors of children acquiring refractory Mycoplasma pneumoniae pneumonia:a meta-analysis[J].Medicine(Baltimore),2021,100(11):e24894.
[14] 罗永涵,代继宏.儿童支原体肺炎合并肺不张行多次支气管肺泡灌洗术的危险因素分析[J].陆军军医大学学报,2022,44(18):1856-1861.
[15] LIN Y,WANG Y,LI P F.Mutual regulation of lactate dehydrogenase and redox robustness[J].Front Physiol,2022,13:1038421.
[16] SHEN F,DONG C,ZHANG T,et al.Development of a Nomogram for predicting refractory Mycoplasma pneumoniae pneumonia in children[J].Front Pediatr,2022,10:813614.
[17] SPROSTON N R,ASHWORTH J J.Role of C-reactive protein at sites of inflammation and infection[J].Front Immunol,2018,9:754.
[18] CHEN Q,HU T,WU L,et al.Clinical features and biomarkers for early prediction of refractory Mycoplasma pneumoniae pneumonia in children[J].Emerg Med Int,2024,2024:9328177.
[19] HUANG L,HUANG X,JIANG W,et al.Independent predictors for longer radiographic resolution in patients with refractory Mycoplasma pneumoniae pneumonia:a prospective cohort study[J].BMJ Open,2018,8(12):e023719.
[20] 乜明金,刘丽娟,李莉,等.肺炎支原体感染患儿合并支气管黏液堵塞的危险因素及其列线图模型构建与验证[J].中华医院感染学杂志,2023,33(19):3009-3012. |